Tocqueville Asset Management L.P. Pulse Biosciences, Inc. Transaction History

Tocqueville Asset Management L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 14, 2018	SELL	$12.67 - $24.69 $272,405 - $530,835	-21,500 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$18.81 - $30.33 $28,214 - $45,495	1,500 Added 7.5%	21,500 $507,000
Q3 2017 Oct 30, 2017	BUY	$10.26 - $24.97 $205,200 - $499,400	20,000	20,000 $372,000

4.8M

138K

96.2K

Ticker PLSE
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 37,125,900
Market Cap $541M
Description
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

Stay updated on Tocqueville Asset Management L.P. with notifications on news.